StayCurrentMD · Primary Posterior Sagittal Anorectoplasty Outcomes for Rectovestibular and Perineal Fistulas Using an Accelerated Pathway: a Single Institution Study
Article1 min read·Published Jun 2019Older

Primary Posterior Sagittal Anorectoplasty Outcomes for Rectovestibular and Perineal Fistulas Using an Accelerated Pathway: a Single Institution Study

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jun 2019 · 1 min read

In brief

In brief

Single-center review of 63 patients with anorectal malformations treated with PSARP using an accelerated postoperative pathway showed comparable outcomes to historical series with median 3-day hospital stay and minimal complications. Early refeeding and reduced antibiotic use appear safe in selected patients, including those undergoing primary repair without diversion.

Written by the GCMD Library team from the article.

Abstract

Background

Posterior sagittal anorectoplasty (PSARP) is the most common surgical treatment for patients with anorectal malformations. Such patients are often subjected to prolonged nil per os (NPO), antibiotic use, and use of parenteral nutrition. Our aim was to review our institutional experience with patients undergoing PSARP using an accelerated standardized postoperative pathway.

Methods

Our hospital database was queried from 2004 to 2016 for patients diagnosed with imperforate anus who underwent a surgical procedure. Short term outcomes, hospital length of stay (LOS), and cost were evaluated.

Results

Sixty-three patients were identified during the study period. Of these patients, 34 (54.0%) had a fistula to the urogenital tract or had no demonstrable fistula and one cloaca and 29 (46.0%) had a fistula in the perineum. Approximately half of patients underwent primary PSARP, including 8 patients with fistulas located in the vestibule and vagina in girls and two with no apparent fistulas (12.7% of total cohort). Only two postoperative complications occurred: one superficial surgical site infection and one perineal wound dehiscence. Among the whole cohort, median LOS was 3 days. Median time to PO intake was 2 days, and median cost was $11,532. No complications occurred among the subset of 8 patients undergoing primary PSARP.

Conclusion

Patients undergoing PSARP experienced similar outcomes compared to historical series, suggesting that the accelerated pathway for early refeeding and reduced use of antibiotics may be beneficial in appropriately selected patients.

Type of study

Case series with no comparison group

Level of evidence

Level IV.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →